Medical device benefit-risk analysis is a structured evaluation of whether the clinical benefits of a device outweigh its residual risks. It is mandated under ISO 14971:2019, FDA regulations, and EU MDR. Thus, it is critical for regulatory approval, patient safety,...
FDA design and development planning is a structured process mandated under 21 CFR Part 820 (Quality System Regulation). It serves as the mandated roadmap for controlling a medical device’s progression from initial concept to a validated product. It ensures...
Medical device development is a structured and highly regulated process. It takes a product from concept through design, testing, regulatory approval, and post-market monitoring to ensure safety, effectiveness, and compliance. It involves multiple phases, each with...
Planning and designing a pharma manufacturing facility means creating a controlled, compliant, and efficient environment. This environment ensures safe and high-quality medicines are consistently produced. It involves careful site selection, zoning of clean and...
Design control for medical devices is a structured regulatory-mandated process. It ensures medical devices are designed to be safe, effective, and meet user needs before they reach the market. It is required under FDA’s 21 CFR, ISO 13485:2016, and indirectly under EU...